Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)
BelgiumStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
BelgiumStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
BelgiumStudy of Ropivacaine for Pain Control in Patients Having Open Heart Surgery Through Chest Bone Incision
BelgiumStudy of HPV antibody response in urine samples before and after HPV 9-valent vaccine in people with human Papillomavirus infection
BelgiumComparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation
BelgiumStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
BelgiumStudy of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants
BelgiumStudy of nirogacestat in adult premenopausal women with desmoid tumors and aggressive fibromatosis to evaluate ovarian function recovery
BelgiumStudy of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis
BelgiumA study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
BelgiumStudy of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
